Cargando…
When is Genomic Testing Cost-Effective? Testing for Lynch Syndrome in Patients with Newly-Diagnosed Colorectal Cancer and Their Relatives
Varying estimates of the cost-effectiveness of genomic testing applications can reflect differences in study questions, settings, methods and assumptions. This review compares recently published cost-effectiveness analyses of testing strategies for Lynch Syndrome (LS) in tumors from patients newly d...
Autor principal: | Grosse, Scott D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604059/ https://www.ncbi.nlm.nih.gov/pubmed/26473097 http://dx.doi.org/10.3390/healthcare3040860 |
Ejemplares similares
-
Genetic Testing for Lynch Syndrome in Individuals Newly Diagnosed with Colorectal Cancer to Reduce Morbidity and Mortality from Colorectal Cancer in Their Relatives
por: Coates, Ralph, et al.
Publicado: (2011) -
Psychological distress in newly diagnosed colorectal cancer patients following microsatellite instability testing for Lynch syndrome on the pathologist’s initiative
por: Landsbergen, K. M., et al.
Publicado: (2012) -
Recognition of Lynch Syndrome Amongst Newly Diagnosed Colorectal Cancers at St. Paul's Hospital
por: Pi, Steven, et al.
Publicado: (2017) -
The predicted impact and cost‐effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome
por: Kang, Yoon‐Jung, et al.
Publicado: (2019) -
Prevalence of Lynch Syndrome among Patients with Newly Diagnosed Endometrial Cancers
por: Egoavil, Cecilia, et al.
Publicado: (2013)